(NASDAQ: MRUS) Merus Nv's forecast annual revenue growth rate of 95.8% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.17%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.07%.
Merus Nv's revenue in 2025 is $36,133,000.On average, 6 Wall Street analysts forecast MRUS's revenue for 2025 to be $3,116,671,057, with the lowest MRUS revenue forecast at $867,085,386, and the highest MRUS revenue forecast at $6,218,142,210. On average, 6 Wall Street analysts forecast MRUS's revenue for 2026 to be $6,102,277,493, with the lowest MRUS revenue forecast at $700,577,356, and the highest MRUS revenue forecast at $22,240,221,971.
In 2027, MRUS is forecast to generate $21,056,149,513 in revenue, with the lowest revenue forecast at $451,851,667 and the highest revenue forecast at $65,649,763,644.